Until vaccines against COVID-19 become available, ‘testing, testing and more testing’ to support the detection of cases and isolation of patients is the only effective strategy against the disease.
Kunal Jain, from IMAP India’s team, summarises the pharmaceutical progress on treatments for Covid-19 and highlights from a recent virtual conference on this subject in Israel the steps being taken across the world on a possible cure to halt the spread of the virus.
This figure is higher than the average posted during Q1-Q3 2020, suggesting that the rebound in market activity observed in Q4 2020, in which IMAP closed a record 83 deals, has carried over.
Moravia Containers Group now consists of three highly established and reputable Czech manufacturers of modular buildings.
IMAP closes 218 M&A deals worth over $12.5 billion. Q4 2020 marked IMAP’s strongest quarter ever.
